Short α-helical peptides

General Information


DRACP ID  DRACP00479

Peptide Name   Short α-helical peptides

Sequence  GIIKKIIKKIIKKI

Sequence Length  14

UniProt ID  Not available

PubChem CID  Not available

Origin  Alpha-helical proteins

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma 95% Cytotoxicity at 4 µM Approx MTT assay 24 h 1
HL-60 Adult acute myeloid leukemia; Acute myeloid leukemia Leukemia 90% Cytotoxicity at 5 µM Approx MTT assay 24 h 1

Hemolytic Activity  Human erythrocytes: HC50>250 µM

Normal (non-cancerous) Cytotoxicity  Human keratinocytes HaCat: <5% Killing=40 µM

Target  Not available

Affinity  Not available

Mechanism  In addition to rapid membrane-permeabilizing capacities, the peptides can also induce the programmed cell death of cancer cells via both mitochondrial pathway and death receptor pathway, without inducing non-specific immunogenic responses.

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00479

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C80H154N20O15

Absent amino acids  ACDEFHLMNPQRSTVWY

Common amino acids  I

Mass  186831

Pl  11.5

Basic residues  6

Acidic residues  0

Hydrophobic residues  7

Net charge  6

Boman Index  208

Hydrophobicity  55

Aliphatic Index  195

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24246647

Title  Molecular mechanisms of anticancer action and cell selectivity of short α-helical peptides

Doi 10.1016/j.biomaterials.2013.10.082

Year  2014

Literature 2

Pubmed ID Not available

Title  Amino acid side chains affect the bioactivity of designed short peptide amphiphiles

Doi 10.1039/C6TB00155F

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.